US-China trade war alerts top Beijing deal maker CDH to more buyout opportunities at home as foreign firms trim assets
- CDH Investments sees more opportunities at home, if and when foreign multinationals pare their assets to minimise risk
- Private-equity firm cites semiconductor and pharmaceutical sectors as key growth areas as China welcomes an influx of experts caught in spat with US
CDH Investments is eyeing buyout opportunities at home, at a time when global companies are turning away from China to lessen the pain from a year-long trade war and geopolitical tensions.
“It is an opportunity we have been noticing, and we have been monitoring some of the pipeline deals,” she said in an interview in Hong Kong. “If there are good spin-off opportunities, we would love [to invest].”
Under the cloud of the US-China trade war, domestic players are seeing a pick up in deal prospects in the technology, manufacturing and health care sectors in particular, she added.
Beijing-based CDH, founded in 2002, made its name by backing top domestic groups that include the world’s largest pork producer, WH Group, and Mengniu Dairy. It also invested early on in Belle International Holdings, China’s largest women’s footwear retailer, which recently spun off sportswear arm Topsports International in an IPO that raised US$1 billion in Hong Kong.